Related Experiment Video
Updated: Feb 14, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Current status of stem cells in cardiac repair
1Department of Environmental & Occupational Health, College of Public Health, University of South Florida & the James A Haley Hospital, Tampa, FL 33612-3805, USA.
Insights
Acute myocardial infarction (AMI) and congestive heart failure (CHF) affect millions. This review explores stem cell therapies, including embryonic, cardiac, bone marrow, and mesenchymal stem cells, as innovative treatments for these prevalent heart conditions.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- High lifetime incidence of acute myocardial infarction (AMI) affects men and women over 40.
- Increased survival post-AMI leads to a rising prevalence of congestive heart failure (CHF).
- Millions in the USA suffer from ischemic cardiomyopathies and CHF, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review current stem cell investigations for treating AMI and CHF.
- To examine the therapeutic potential of various stem cell types and their derivatives.
Main Methods:
- Review of current scientific literature on stem cell applications in cardiology.
- Analysis of studies involving human embryonic stem cells, cardiac stem/progenitor cells, bone marrow-derived mononuclear cells, and mesenchymal stem cells.
- Inclusion of research on stem cell paracrine factors and exosomes.
Main Results:
- Ongoing investigations explore diverse stem cell sources for cardiac repair.
- Stem cell paracrine factors and exosomes are emerging as potential therapeutic agents.
Conclusions:
- Stem cell-based therapies show promise for treating acute myocardial infarction and congestive heart failure.
- Further research into stem cell paracrine factors and exosomes is warranted for novel treatment strategies.
Abstract:
One out of every two men and one out of every three women greater than the age of 40 will experience an acute myocardial infarction (AMI) at some time during their lifetime. As more patients survive their AMIs, the incidence of congestive heart failure (CHF) is increasing. 6 million people in the USA have ischemic cardiomyopathies and CHF. The search for new and innovative treatments for patients with AMI and CHF has led to investigations and use of human embryonic stem cells, cardiac stem/progenitor cells, bone marrow-derived mononuclear cells and mesenchymal stem cells for treatment of these heart conditions. This paper reviews current investigations with human embryonic, cardiac, bone marrow and mesenchymal stem cells, and also stem cell paracrine factors and exosomes.
Related Concept Videos
Mismatch Repair
Overview of DNA Repair
Chemically...
Adult Stem Cells
Embryonic Stem Cells
Base Excision Repair
The first step of...
Nucleotide Excision Repair

